Reports

ROCHESTER, Minn. — Mayo Clinic Cancer Center has opened a new Phase I clinical trial testing an engineered measles virus against multiple myeloma, a cancer of the bone marrow that currently has no cure. This is the third of a series of molecular medicine studies in patients testing the potential of measles to kill cancer.

By The Unknown Patient


Source: The International Myeloma Foundation, Myeloma Minute – February 3, 2007 (abridged)

Report of the EMP Board of Directors in behalf of the Annual General Meeting, To be held on May 30, 2008 in Brussels, Belgium.

by Greetje Goossens

The 49th Annual American Society of Hematology (ASH) Meeting was held in Atlanta, Georgia from 8-11 December 2007. This meeting provided hematologists from around the world a forum for discussing current and critical issues in hematology. The latest research and treatments for blood disorders, including multiple myeloma, were presented at this meeting.

Report of the ‘Patient Forum’ of the ECCO 14 conference, September 23-24 2007, Barcelona.

ECCO, the European Cancer Organisation, organises every 2 years a multidisciplinary congress. EMP was represented by Greetje Goossens, Ilse Hein, Joao Salazar and Lia van Ginneken.